Dr. Jeff Dobro

Advisor

About Dr. Dobro

Dr. Jeff Dobro is the Chief Innovation Officer at Transcarent, the first comprehensive, consumer-directed health and care platform for employees of self-insured employers and their families. At Transcarent, Jeff leads the organizations’ efforts to develop and bring novel products and partnerships to the market. His interests span from furthering evidence-based health initiatives to innovative opportunities that deliver trusted, simple, seamless, and connected solutions that drive value for our clients, Members and the providers themselves.

Prior to joining Transcarent, Jeff was a Partner and the Health Strategy and Innovation Leader at Mercer Consulting. He was the Chief Medical Officer at One Medical, designing the company’s innovative model of care and was responsible for the company’s B2B strategy. Jeff has also served as the Chief Medical Officer at RedBrick Health (now Virgin Pulse) where he was responsible for the company’s clinical programs (wellbeing, disease management, medication therapy management). Jeff led design, development, and ongoing operations of the clinical and coaching programs as well as leading outcomes research for a range of population health programs.

Previously, he was a Partner at Willis Towers Watson, where he was responsible for employer-based population health management programs, employer-provider direct contracting and onsite/near site clinics. He has operated a national group of 58 primary care medical practices, was Chief Medical Officer of an early ACO management firm and was an analyst at a hedge fund.

Jeff is a board-certified internist and rheumatologist and an Associate Professor at NYU School of Medicine.

When not redesigning systems of health, you can find Jeff kayaking or biking, reading novels, discovering new music, studying the latest advances in medicine, learning ukulele and hanging out with his family.